TRNS vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

TRNS

54.6
AI Score
VS
TRNS Wins

MLAB

40.8
AI Score

Investment Advisor Scores

TRNS

55score
Recommendation
HOLD

MLAB

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric TRNS MLAB Winner
Revenue 92.94M 60.14M TRNS
Net Income 1.33M 2.83M MLAB
Gross Margin 33.1% 64.9% MLAB
Net Margin 1.4% 4.7% MLAB
Operating Income 3.72M 7.03M MLAB
ROE 0.4% 1.5% MLAB
ROA 0.3% 0.7% MLAB
Total Assets 492.63M 419.22M TRNS
Cash 6.71M 30.70M MLAB
Debt/Equity 0.36 0.35 MLAB
Current Ratio 2.49 1.79 TRNS
Free Cash Flow 4.83M 14.18M MLAB

Relative Price Performance (Last 90 Days)

TRNS 1M: -13.8% · 3M: -7.2% MLAB 1M: +7.2% · 3M: +12.6%

Current Technical Phase

TRNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 42

RSI (14): 41.6 · Price: $84.31

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.3% over 20 days), RSI 53

RSI (14): 52.9 · Price: $120.87

Fundamentals Snapshot

Metric TRNS MLAB
Market Cap
Forward P/E 40.8 22.4
Trailing P/E 235.3 143.9
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.3% 0.6%
Operating Margin 0.1% 0.1%
EPS 0.35 0.84
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, TRNS is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.